135 related articles for article (PubMed ID: 11418352)
1. Maturation of IgG avidity to individual rubella virus structural proteins.
Nedeljkovic J; Jovanovic T; Oker-Blom C
J Clin Virol; 2001 Aug; 22(1):47-54. PubMed ID: 11418352
[TBL] [Abstract][Full Text] [Related]
2. Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells.
Nedeljkovic J; Jovanovic T; Mladjenovic S; Hedman K; Peitsaro N; Oker-Blom C
J Clin Virol; 1999 Oct; 14(2):119-31. PubMed ID: 10588454
[TBL] [Abstract][Full Text] [Related]
3. Differential IgG avidity to rubella virus structural proteins.
Mauracher CA; Mitchell LA; Tingle AJ
J Med Virol; 1992 Mar; 36(3):202-8. PubMed ID: 1564450
[TBL] [Abstract][Full Text] [Related]
4. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
[TBL] [Abstract][Full Text] [Related]
6. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.
Mitchell LA; Ho MK; Rogers JE; Tingle AJ; Marusyk RG; Weber JM; Duclos P; Tepper ML; Lacroix M; Zrein M
J Clin Microbiol; 1996 Sep; 34(9):2210-8. PubMed ID: 8862587
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model.
Cusi MG; Valassina M; Bianchi S; Wunner W; Valensin PE
Virus Res; 1995 Aug; 37(3):199-208. PubMed ID: 8533457
[TBL] [Abstract][Full Text] [Related]
9. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing.
Hedman K; Hietala J; Tiilikainen A; Hartikainen-Sorri AL; Räihä K; Suni J; Väänänen P; Pietiläinen M
J Med Virol; 1989 Apr; 27(4):293-8. PubMed ID: 2656909
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune response after primary rubella virus infection and after vaccination.
Vauloup-Fellous C; Grangeot-Keros L
Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
[TBL] [Abstract][Full Text] [Related]
11. Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity.
Vauloup-Fellous C; Ursulet-Diser J; Grangeot-Keros L
Clin Vaccine Immunol; 2007 Nov; 14(11):1416-9. PubMed ID: 17913862
[TBL] [Abstract][Full Text] [Related]
12. Immunoaffinity purification of baculovirus-expressed rubella virus E1 for diagnostic purposes.
Lindqvist C; Schmidt M; Heinola J; Jaatinen R; Osterblad M; Salmi A; Keränen S; Akerman K; Oker-Blom C
J Clin Microbiol; 1994 Sep; 32(9):2192-6. PubMed ID: 7814545
[TBL] [Abstract][Full Text] [Related]
13. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women.
Hofmann J; Liebert UG
J Virol Methods; 2005 Dec; 130(1-2):66-71. PubMed ID: 16024097
[TBL] [Abstract][Full Text] [Related]
14. Maturation of rubella IgG avidity over time after acute rubella infection.
Böttiger B; Jensen IP
Clin Diagn Virol; 1997 Aug; 8(2):105-11. PubMed ID: 9316732
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune response to primary rubella virus infection.
Wilson KM; Di Camillo C; Doughty L; Dax EM
Clin Vaccine Immunol; 2006 Mar; 13(3):380-6. PubMed ID: 16522781
[TBL] [Abstract][Full Text] [Related]
16. Determination of rubella virus-specific humoral and cell-mediated immunity in pregnant women with negative or equivocal rubella-specific IgG in routine screening.
Picone O; Bouthry E; Bejaoui-Olhmann Y; Cordier AG; Nedellec S; Letourneau A; Carbonel M; Brollo M; Grangeot-Keros L; Ayoubi JM; Benachi A; Rouge E; Vauloup-Fellous C
J Clin Virol; 2019 Mar; 112():27-33. PubMed ID: 30711798
[TBL] [Abstract][Full Text] [Related]
17. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
Hamkar R; Jalilvand S; Mokhtari-Azad T; Nouri Jelyani K; Dahi-Far H; Soleimanjahi H; Nategh R
J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863
[TBL] [Abstract][Full Text] [Related]
18. Differential antibody responses to rubella virus infection in males and females.
Mitchell LA; Zhang T; Tingle AJ
J Infect Dis; 1992 Dec; 166(6):1258-65. PubMed ID: 1431244
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
[TBL] [Abstract][Full Text] [Related]
20. Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection.
Takahashi S; Machikawa F; Noda A; Oda T; Tachikawa T
Clin Diagn Lab Immunol; 1998 Jan; 5(1):24-7. PubMed ID: 9455874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
